Collegium Pharmaceutical (COLL) PT Raised to $45 at Piper Sandler May 7, 2026 02:14PM
Collegium Pharma (COLL) Tops Q1 EPS by 13c ; Offers Guidance May 7, 2026 07:41AM
Truist: 'We like the risk/reward setup for Collegium Pharmaceutical (COLL)' Apr 16, 2026 09:03AM
Jefferies likes Collegium Pharmaceutical (COLL) Azstarys acquisition Mar 19, 2026 05:28PM
Barclays on Collegium Pharmaceutical (COLL): 'we would add to positions at this level' Mar 19, 2026 12:45PM


Feb 10, 2026 06:15AM Collegium Pharmaceutical (COLL) PT Raised to $58 at Truist Securities
Jan 8, 2026 08:01AM Collegium Pharmaceutical issues 2026 financial guidance
Nov 6, 2025 08:07AM Collegium Pharma (COLL) Tops Q3 EPS by 37c ; Offers Guidance
Aug 11, 2025 06:37AM H.C. Wainwright Assumes Collegium Pharmaceutical (COLL) at Buy
Aug 7, 2025 04:08PM Collegium Pharmaceutical (COLL) PT Raised to $45 at Truist Securities
Aug 7, 2025 07:53AM Collegium Pharma (COLL) Tops Q2 EPS by 2c ; Offers Guidance
Jul 7, 2025 08:00AM Collegium pharmaceutical authorizes $150 million share buyback program
May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing
May 12, 2025 08:05AM Collegium Pharma (COLL) Announces $25M Accelerated Share Buyback
Mar 26, 2025 07:02AM Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board
Mar 24, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Collegium Pharmaceutical (COLL)
Mar 17, 2025 07:02AM Collegium Pharma (COLL) Announces Updates to its Board of Directors and Executive Leadership Team
Feb 27, 2025 04:35PM Collegium Pharma (COLL) Tops Q4 EPS by 9c, provides guidance
Feb 5, 2025 08:02AM Collegium Pharma (COLL) Appoints Nancy S. Lurker to its Board
Feb 4, 2025 07:03AM Collegium Pharmaceutical (COLL) PT Lowered to $36 at Piper Sandler
Jan 8, 2025 08:03AM Collegium Pharma (COLL) Provides 2025 Financial Guidance and Business Update
Nov 11, 2024 03:55PM Collegium Pharmaceutical (COLL) PT Lowered to $40 at Jefferies
Nov 7, 2024 04:55PM Collegium Pharma (COLL) Tops Q3 EPS by 4c
Nov 7, 2024 04:02PM Collegium Pharma (COLL) Appoints Vikram Karnani as CEO
Oct 11, 2024 08:00AM Piper Sandler Reiterates Neutral Rating on Collegium Pharmaceutical (COLL)
Sep 5, 2024 06:36AM Collegium Pharmaceutical (COLL) PT Raised to $50 at H.C. Wainwright
Aug 9, 2024 09:15AM Collegium Pharmaceutical (COLL) PT Lowered to $37 at Piper Sandler
Aug 8, 2024 04:08PM Collegium Pharma (COLL) Misses Q2 EPS by 3c, provides guidance
Jun 13, 2024 08:02AM Collegium Pharma (COLL) Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise